Faculty Profiles - NAKAMURA Kazufumi

Papers - NAKAMURA Kazufumi

Division display 141 - 160 of about 261 ／ All the affair displays >>

QT延長症候群の診断に苦慮した1例

高谷陽一, 森田宏, 麻植浩樹, 杜徳尚, 吉田賢司, 谷山真規子, 三好亨, 西井伸洋, 永瀬聡, 中村一文, 河野普久, 草野研吾, 伊藤浩

心電図 33 ( Suppl.4 ) S - 154 2013.9

PGI2経口薬をベースとした併用療法 PGI2(ベラプロスト)封入ナノ粒子吸入によるモノクロタリン誘発性肺高血圧の改善経口薬を吸入にする新たな試み

赤木達, 中村一文, 草野研吾, 伊藤浩

Therapeutic Research 34 ( 9 ) 1202 - 1202 2013.9

BAL所見が診断に有用であった持続性心室頻拍を伴う心室瘤の1例

和田匡史, 草野研吾, 西井伸洋, 永瀬聡, 森田宏, 中村一文, 河野晋久, 伊藤浩

心臓 45 ( Suppl.2 ) 91 - 91 2013.8

Serum cystatin C as a biomarker of cardiac diastolic dysfunction in patients with cardiac disease and preserved ejection fraction. Reviewed

Nosaka K, Nakamura K, Kusano K, Toh N, Tada T, Miyoshi T, Doi M, Kohno K, Morita H, Ito H

Congestive heart failure (Greenwich, Conn.) 19 ( 4 ) E35 - 9 2013.7

Brugada症候群の夜間・徐脈時の心室遅延電位の特徴の検討

寒川睦子, 森田宏, 永瀬聡, 西井伸洋, 河野晋久, 中村一文, 草野研吾, 伊藤浩, 亀井成美, 青木佐知子, 越智真金, 信定さおり, 川下隆二, 岡田健, 大江透

心電図 33 ( Suppl.2 ) S - 29 2013.5

メタボリックシンドローム患者におけるベザフィブラートの血管内皮機能への影響

大野佑子, 麻植浩樹, 三好亨, 杜徳尚, 河野晋久, 中村一文, 永瀬聡, 森田宏, 草野研吾, 伊藤浩

超音波医学 40 ( Suppl. ) S703 - S703 2013.4

Safety and Efficacy of a Bolus Injection of Landiolol Hydrochloride as a Premedication for Multidetector-Row Computed Tomography Coronary Angiography

OSAWA Kazuhiro, MIYOSHI Toru, SATO Shuhei, AKAGI Noriaki, MORIMITSU Yusuke, NAKAMURA Kazufumi, KOHNO Kunihisa, KUSANO Kengo, KANAZAWA Susumu, ITO Hiroshi

JAPANESE CIRCULATION JOURNAL 77 ( 1 ) 146 - 152 2012.12

Language：English Publisher：The Japanese Circulation Society

Background: We evaluated the safety and efficacy of a bolus injection of landiolol hydrochloride, an ultrashort-acting β1-selective antagonist, as an additional treatment after premedication with an oral β-blocker to reduce heart rate prior to multidetector-row computed tomography (MDCT) coronary angiography (CAG). Methods and Results: A total of 458 patients who underwent MDCT CAG were retrospectively enrolled. Image quality and hemodynamic parameters were compared in patients before and after approval of landiolol hydrochloride. If heart rate reduction was insufficient after premedication with an oral β-blocker, a bolus injection of landiolol hydrochloride (n=66) or other drugs (n=30) was used. The percentage of evaluable images per segment in patients after approval of landiolol (99.3%) was greater than that in patients before approval of landiolol (97.4%, P<0.01). Heart rates before scanning in patients receiving landiolol hydrochloride were similar to those receiving other drugs. Heart rate was significantly reduced approximately 5min after injection of landiolol hydrochloride and increased shortly. No decrease in systolic blood pressure or other adverse effects was observed. Conclusions: Bolus injection of landiolol hydrochloride sufficiently reduced heart rate without significantly reducing systolic blood pressure and produced a high percentage of evaluable images, suggesting that bolus injection of landiolol hydrochloride as an additional pretreatment is feasible in MDCT CAG. (Circ J 2013; 77: 146–152)<br>

DOI： 10.1253/circj.CJ-12-0663

CiNii Article

CiNii Books

researchmap

Other Link： http://search.jamas.or.jp/link/ui/2013357873

[Oxidative stress and calcium overload in heart failure].

Kazufumi Nakamura, Daiji Miura, Hiromi Matsubara, Hiroshi Ito

Nihon yakurigaku zasshi. Folia pharmacologica Japonica 140 ( 6 ) 265 - 9 2012.12